Form 4: HilleVax Director Sells Shares Post-Merger

HilleVax Director Nanette Cocero reported the disposition of common stock and vested RSUs following the company's merger with XOMA Royalty Corporation.

Summary

• Nanette Cocero, a Director of HilleVax, Inc., reported a disposition of securities.
• The transaction occurred on September 17, 2025, in connection with the completion of a merger.
• HilleVax, Inc. was acquired by XOMA Royalty Corporation ('Parent') and XRA 4 Corp. ('Merger Sub').
• Shareholders received $1.95 in cash per share plus one contingent value right (CVR) for certain contingent cash payments.
• 17,199 shares of Common Stock were disposed of directly by Nanette Cocero.
• Outstanding restricted stock units (RSUs) vested immediately prior to the merger's effective time and were exchanged for cash ($1.95 per underlying share) and one CVR per underlying share.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual report of a completed transaction (merger) and insider share disposition, not an operational update or new strategic initiative.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders of HilleVax, Inc. received $1.95 in cash and one CVR per share, indicating the completion of their investment in the company.
• Employees holding RSUs had their units vested and converted into cash and CVRs, impacting their equity compensation.

Key Dates

Keywords

HilleVax, HLVX, XOMA Royalty Corporation, Merger, Acquisition, Form 4, Insider Transaction, Nanette Cocero, Contingent Value Right, CVR, Common Stock, RSU